US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Metsera Inc.

70.50

0.0000

Volume:- -

Turnover:- -

Market Cap:7.43B

PE:-11.96

High:70.50

Open:70.50

Low:70.50

Close:70.50

52wk High:83.86

52wk Low:12.30

Shares:105.38M

Float Shares:64.51M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.8924

EPS(LYR):-14.4907

ROE:-134.66%

ROA:-38.77%

PB:22.03

PE(LYR):-4.87

Loading ...

Overview Company News Filings

Pfizer Shares up 0.3%, Novo Nordisk Shares Down 0.5%

THOMSON REUTERS

Metsera Inc trading resumes

BRIEF-Pfizer Says Drug Pricing Agreement With US Government Has No Impact On 2025 Guidance

Novo Nordisk - Updated Proposal Has Been Declared Superior by Metsera's Board of Directors

THOMSON REUTERS

Novo Nordisk - Proposal Subject to Terms of Pfizer's Merger Agreement

THOMSON REUTERS

Novo Nordisk - to Buy Metsera Shares at $62.20 per Share

THOMSON REUTERS

Pfizer CEO Says "Our Belief in the Promise of the Pfizer and Metsera Combination Is Strong and Unwavering" - Prepared Remarks

THOMSON REUTERS

Pfizer CEO: Going Forward, Cost Management Across Our Manufacturing Network Remains a Top Priority - Prepared Remarks

THOMSON REUTERS

Novo Nordisk Submits Amended Proposal to Acquire Metsera

MT Newswires Live

BRIEF-Pfizer And Novo Nordisk Sweeten Offers For Metsera As Bidding War Intensifies - FT

Novo Nordisk sweetens bid for Metsera with an offer of up to $10 billion

Pfizer and Novo Nordisk Sweeten Offers for Metsera as Bidding War Intensifies - FT

THOMSON REUTERS

Metsera Board Deems Novo Nordisk Offer Superior but Reaffirms Support for Pfizer Deal

Metsera Inc: Revised Pfizer Proposal Adopted Same Commercially Reasonable Efforts Standard for CVR as in Novo Nordisk Proposal

THOMSON REUTERS

Metsera Inc: Revised Pfizer Proposal Required a Shareholder of Metsera to Sell Pfizer 14.9% of Common Stock of Metsera Upon Signing of Transaction

THOMSON REUTERS

Metsera Inc - Novo Nordisk Proposal Values Metsera at $86.20 per Share, $10 Bln Total

THOMSON REUTERS

Metsera Inc - Pfizer Merger Agreement Remains in Effect

THOMSON REUTERS

Metsera: Revised Pfizer Proposal Required Co to Issue a Release Stating "Novo Nordisk Proposal Presented Unacceptably High Risks and Was Unviable"

THOMSON REUTERS

Pfizer (PFE.US) Q3 Earnings Beat Expectations and Raises Full-Year Profit Guidance, Bids for Weight-Loss Drug Firm Metsera

RPT-BREAKINGVIEWS-Pfizer’s obesity takeover requires a booster shot

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MTSR/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MTSR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","market":"US","secType":"STK","nameCN":"Metsera Inc.","latestPrice":70.5,"timestamp":1774296000000,"preClose":70.5,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":64513712,"shares":105376189,"eps":-5.892395,"marketStatus":"Not Yet Opened","change":0,"latestTime":"03-23 16:00:00 EDT","open":70.5,"high":70.5,"low":70.5,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.892395,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774339200000},"marketStatusCode":0,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":70.5,"volumeRatio":0,"impliedVol":0.3139,"impliedVolPercentile":0.2016},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","floatShares":64513712,"roa":"-38.77%","roe":"-134.66%","lyrEps":-14.490661,"shares":105376189,"dividePrice":0,"high":70.5,"amplitude":0,"preClose":70.5,"low":70.5,"week52Low":12.3,"pbRate":"22.03","week52High":83.8599,"institutionHeld":0,"latestPrice":70.5,"eps":-5.892395,"divideRate":0,"volume":0,"delay":0,"ttmEps":-5.892395,"open":70.5,"prevYearClose":70.5,"prevWeekClose":70.5,"prevMonthClose":70.5,"prevQuarterClose":70.5,"fiveDayClose":70.5,"twentyDayClose":70.5,"sixtyDayClose":70.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTSR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"MTSR","reason":null,"defaultRemindTime":1763130600000,"announcedDate":"2025-11-12","type":"delisting","dateTimestamp":1763096400000},{"market":"US","date":"2025-11-12","symbol":"MTSR","fiscalQuarterEnding":"2025/09","expectedEps":-0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-1.11},{"market":"US","date":"2025-07-28","symbol":"MTSR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1753675200000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2025-05-12","symbol":"MTSR","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-1.03},{"market":"US","date":"2025-03-26","symbol":"MTSR","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"pre","actualEps":-3.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTSR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTSR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1761886800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MTSR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MTSR","date":"2025-11-14","current":-11.964575,"percent":0.036082,"low":-55.8522,"twenty":-17.976689,"median":-12.456963,"eighty":-10.995731,"high":-6.570442,"avg":-14.489177,"sd":5.001483,"marketCap":7429021324},"quantilePoints":[{"date":"2025-02-07","current":-17.973411,"twenty":-17.939327,"median":-17.8882,"eighty":-17.837073,"marketCap":3042628924},{"date":"2025-02-14","current":-18.277736,"twenty":-18.639274,"median":-18.277736,"eighty":-17.958804,"marketCap":3094146515},{"date":"2025-02-21","current":-19.257661,"twenty":-19.263748,"median":-18.612493,"eighty":-17.973411,"marketCap":3260033158},{"date":"2025-02-28","current":-15.222317,"twenty":-19.263748,"median":-18.292952,"eighty":-17.802989,"marketCap":2576909901},{"date":"2025-03-07","current":-16.749262,"twenty":-19.257661,"median":-17.973411,"eighty":-16.634383,"marketCap":2835398748},{"date":"2025-03-14","current":-15.094245,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":2555229332},{"date":"2025-03-21","current":-17.309229,"twenty":-18.72205,"median":-17.732316,"eighty":-15.847091,"marketCap":2930192911},{"date":"2025-03-28","current":-15.074845,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":3152557072},{"date":"2025-04-04","current":-10.624224,"twenty":-18.709149,"median":-17.433667,"eighty":-15.417782,"marketCap":2221812131},{"date":"2025-04-11","current":-6.570442,"twenty":-18.612493,"median":-16.926585,"eighty":-14.065167,"marketCap":1374056864},{"date":"2025-04-17","current":-8.815846,"twenty":-18.585291,"median":-16.597864,"eighty":-11.231036,"marketCap":1843631343},{"date":"2025-04-25","current":-10.639294,"twenty":-18.362232,"median":-16.039969,"eighty":-10.465489,"marketCap":2224963638},{"date":"2025-05-02","current":-11.734368,"twenty":-18.283822,"median":-15.629326,"eighty":-9.926993,"marketCap":2453973115},{"date":"2025-05-09","current":-12.437626,"twenty":-18.170614,"median":-15.417782,"eighty":-10.4896,"marketCap":2601043422},{"date":"2025-05-16","current":-10.120836,"twenty":-18.143134,"median":-15.084545,"eighty":-9.926993,"marketCap":2690472328},{"date":"2025-05-23","current":-11.083125,"twenty":-18.007321,"median":-13.673351,"eighty":-10.08689,"marketCap":2946282563},{"date":"2025-05-30","current":-10.903313,"twenty":-17.962456,"median":-12.437626,"eighty":-10.237022,"marketCap":2898482293},{"date":"2025-06-06","current":-11.330119,"twenty":-17.863854,"median":-12.078462,"eighty":-10.380871,"marketCap":3011942274},{"date":"2025-06-13","current":-13.665697,"twenty":-17.760585,"median":-12.111113,"eighty":-10.505751,"marketCap":3632820504},{"date":"2025-06-20","current":-10.950736,"twenty":-17.702451,"median":-12.009847,"eighty":-10.478878,"marketCap":2911088957},{"date":"2025-06-27","current":-11.345927,"twenty":-17.568059,"median":-11.719298,"eighty":-10.542899,"marketCap":3016144495},{"date":"2025-07-03","current":-11.638368,"twenty":-17.408779,"median":-11.681839,"eighty":-10.571353,"marketCap":3093885594},{"date":"2025-07-11","current":-14.388896,"twenty":-17.268165,"median":-11.697647,"eighty":-10.619566,"marketCap":3825072138},{"date":"2025-07-18","current":-17.506951,"twenty":-17.303722,"median":-11.789624,"eighty":-10.623027,"marketCap":4653960333},{"date":"2025-07-25","current":-15.67129,"twenty":-17.246135,"median":-12.009847,"eighty":-10.627238,"marketCap":4165977359},{"date":"2025-08-01","current":-11.259046,"twenty":-17.080186,"median":-12.060267,"eighty":-10.669177,"marketCap":3465782198},{"date":"2025-08-08","current":-10.542344,"twenty":-16.963959,"median":-11.907491,"eighty":-10.669177,"marketCap":3245165568},{"date":"2025-08-15","current":-10.340985,"twenty":-16.859629,"median":-11.799396,"eighty":-10.571353,"marketCap":3183182801},{"date":"2025-08-22","current":-11.194202,"twenty":-16.776854,"median":-11.704228,"eighty":-10.619566,"marketCap":3445821646},{"date":"2025-08-29","current":-11.958684,"twenty":-16.726286,"median":-11.700938,"eighty":-10.623027,"marketCap":3681146051},{"date":"2025-09-05","current":-12.385292,"twenty":-16.634383,"median":-11.74414,"eighty":-10.624224,"marketCap":3812465474},{"date":"2025-09-12","current":-12.712928,"twenty":-16.561345,"median":-11.903146,"eighty":-10.627666,"marketCap":3913318790},{"date":"2025-09-19","current":-12.252191,"twenty":-16.438168,"median":-11.874013,"eighty":-10.639294,"marketCap":3771493814},{"date":"2025-09-26","current":-17.959018,"twenty":-16.749262,"median":-11.907491,"eighty":-10.774419,"marketCap":5528180703},{"date":"2025-10-03","current":-17.681988,"twenty":-17.103908,"median":-11.968922,"eighty":-10.788708,"marketCap":5442905015},{"date":"2025-10-10","current":-17.989799,"twenty":-17.506951,"median":-12.044006,"eighty":-10.863794,"marketCap":5537655780},{"date":"2025-10-17","current":-18.078722,"twenty":-17.750391,"median":-12.092917,"eighty":-10.890458,"marketCap":5565028223},{"date":"2025-10-24","current":-18.000059,"twenty":-17.870095,"median":-12.173695,"eighty":-10.903313,"marketCap":5540814139},{"date":"2025-10-31","current":-21.796385,"twenty":-17.928237,"median":-12.282118,"eighty":-10.950736,"marketCap":6709406898},{"date":"2025-11-07","current":-27.891028,"twenty":-17.959018,"median":-12.385292,"eighty":-10.986017,"marketCap":8585472031},{"date":"2025-11-14","current":-24.134147,"twenty":-17.976689,"median":-12.456963,"eighty":-10.995731,"marketCap":7429021324}],"updateTime":1774288230936},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MTSR\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2580251753","title":"Pfizer Shares up 0.3%, Novo Nordisk Shares Down 0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580251753","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580251753?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:58","pubTimestamp":1762268317,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nL4N3WG1LY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BLSP4239.USD","IE00BLSP4452.SGD","LU1023059063.AUD","LU1057294990.SGD","LU1066053197.SGD","SG9999001176.USD","LU1894683348.USD","BK4007","BK4592","BK4139","IE00BBT3K403.USD","BK4585","LU0122379950.USD","IE00B19Z3581.USD","LU0058720904.USD","LU0225771236.USD","SG9999001176.SGD","IE000M9KFDE8.USD","SG9999013999.USD","BK4533","BK4588","LU0306806265.USD","LU0321505868.SGD","PFE","BK4550","BK4581","BK4599","LU0456855351.SGD","LU0321505439.SGD","BK4534","LU0234572021.USD","SGXZ57979304.SGD","SG9999002224.SGD","SG9999011175.SGD","LU0170899867.USD","LU0868494617.USD","LU1066051498.USD","IE0002270589.USD","LU1883839398.USD","LU0306807586.USD","MTSR","LU0289739699.SGD","SG9999003800.SGD","LU0225284248.USD","SG9999002232.USD","LU0985481810.HKD","IE00B19Z3B42.SGD","BK4568","LU1894683264.USD"],"gpt_icon":0},{"id":"2580755808","title":"Metsera Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2580755808","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580755808?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:55","pubTimestamp":1762268124,"startTime":"0","endTime":"0","summary":"09:55 EST Metsera (MTSR) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/metsera-inc-trading-resumes-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/metsera-inc-trading-resumes-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MTSR","BK4139"],"gpt_icon":0},{"id":"2580755589","title":"BRIEF-Pfizer Says Drug Pricing Agreement With US Government Has No Impact On 2025 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2580755589","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580755589?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:50","pubTimestamp":1762267809,"startTime":"0","endTime":"0","summary":"BRIEF-Pfizer Says Drug Pricing Agreement With US Government Has No Impact On 2025 GuidanceNov 4  - Pfizer:PFIZER CEO SAYS \"OUR BELIEF IN THE PROMISE OF THE PFIZER AND METSERA COMBINATION IS STRONG AND UNWAVERING\" - PREPARED REMARKSPFIZER:  PLANNING TO START PHASE 3 FOR ADULT 25-VALENT PROGRAM STUDY NEXT YEAR, IF FDA ALIGNS WITH OUR APPROACH - PREPARED REMARKSPFIZER: FOR ABRYSVO, IN U.S., EXPERIENCING HEADWIND OF MORE DIFFICULT TO ACTIVATE POPULATION AS WE ENTER THIRD SEASON OF RSV - PREPARED REMARKSPFIZER CFO: GOING FORWARD, COST MANAGEMENT ACROSS OUR MANUFACTURING NETWORK REMAINS A TOP PRIORITY - PREPARED REMARKSPFIZER: DRUG PRICING AGREEMENT WITH US GOVERNMENT HAS NO IMPACT ON 2025 GUIDANCE, EXPECT DILUTIVE IMPACT TO 2026 FINANCIAL OUTLOOK - PREPARED REMARKSPFIZER: THERE IS SOFTNESS IN OUR COVID PRODUCTS DUE TO LOWER VACCINATION RATES AND COVID INFECTION RATES - PREPARED REMARKSPFIZER: NOW EXPECT 2025 ADJUSTED RESEARCH AND DEVELOPMENT TO BE IN THE RANGE OF $10.0 BILLION TO $11.0 BILL","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nL8N3WG24O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE000M9KFDE8.USD","LU0122379950.USD","LU0868494617.USD","LU1894683264.USD","IE00BBT3K403.USD","BK4568","LU1023059063.AUD","BK4534","PFE","IE00B19Z3581.USD","LU0306807586.USD","IE00B19Z3B42.SGD","LU1066051498.USD","BK4599","BK4533","BK4007","BK4592","SG9999003800.SGD","LU0225284248.USD","BK4585","SG9999001176.SGD","LU0306806265.USD","LU0170899867.USD","LU1066053197.SGD","IE0002270589.USD","BK4139","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0234572021.USD","LU0985481810.HKD","SG9999001176.USD","LU1894683348.USD","LU0058720904.USD","LU0225771236.USD","LU0456855351.SGD","SG9999002224.SGD","LU1883839398.USD","MTSR","SG9999011175.SGD","LU0321505868.SGD","LU0321505439.SGD","BK4581","LU0289739699.SGD","SGXZ57979304.SGD","LU1057294990.SGD","SG9999002232.USD","SG9999013999.USD","BK4550"],"gpt_icon":1},{"id":"2580758924","title":"Novo Nordisk - Updated Proposal Has Been Declared Superior by Metsera's Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2580758924","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580758924?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:31","pubTimestamp":1762266695,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"712e45e587dc4f5fe494ffc919703b1d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nTUAMGHML:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MTSR"],"gpt_icon":0},{"id":"2580584827","title":"Novo Nordisk - Proposal Subject to Terms of Pfizer's Merger Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2580584827","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580584827?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:31","pubTimestamp":1762266695,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nTUAMGHML:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MTSR","BK4139"],"gpt_icon":0},{"id":"2580486758","title":"Novo Nordisk - to Buy Metsera Shares at $62.20 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2580486758","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580486758?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:31","pubTimestamp":1762266695,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ba68da69f867f81f24ac210d57b4bbd9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nTUAMGHML:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MTSR","BK4139"],"gpt_icon":0},{"id":"2580775854","title":"Pfizer CEO Says \"Our Belief in the Promise of the Pfizer and Metsera Combination Is Strong and Unwavering\" - Prepared Remarks","url":"https://stock-news.laohu8.com/highlight/detail?id=2580775854","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580775854?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:28","pubTimestamp":1762266531,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nFWN3WG0VM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LU0234572021.USD","BK4568","LU0321505868.SGD","LU0225771236.USD","LU0868494617.USD","BK4550","LU1894683264.USD","BK4534","BK4585","IE00BLSP4239.USD","LU0058720904.USD","BK4139","SG9999003800.SGD","BK4581","LU1894683348.USD","BK4533","SG9999011175.SGD","SGXZ57979304.SGD","BK4592","LU0321505439.SGD","SG9999002232.USD","LU1883839398.USD","LU1057294990.SGD","LU1066053197.SGD","PFE","IE00B19Z3B42.SGD","SG9999013999.USD","IE000M9KFDE8.USD","LU0289739699.SGD","SG9999002224.SGD","LU0306806265.USD","BK4588","IE00BLSP4452.SGD","LU0225284248.USD","IE00B19Z3581.USD","IE0002270589.USD","BK4599","LU0122379950.USD","MTSR","SG9999001176.SGD","SG9999001176.USD","LU1066051498.USD","LU0306807586.USD","LU1023059063.AUD","LU0456855351.SGD","LU0985481810.HKD","IE00BBT3K403.USD","LU0170899867.USD"],"gpt_icon":0},{"id":"2580758922","title":"Pfizer CEO: Going Forward, Cost Management Across Our Manufacturing Network Remains a Top Priority - Prepared Remarks","url":"https://stock-news.laohu8.com/highlight/detail?id=2580758922","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580758922?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:28","pubTimestamp":1762266531,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"58db9dde874c991d22ce1b6e347fe919","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nFWN3WG0VM:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0058720904.USD","LU0321505439.SGD","LU0225284248.USD","SG9999002232.USD","LU0868494617.USD","LU1066053197.SGD","LU0234572021.USD","IE00BLSP4452.SGD","BK4533","SG9999001176.USD","SG9999011175.SGD","IE00BBT3K403.USD","IE00B19Z3581.USD","BK4550","BK4599","LU1057294990.SGD","BK4592","LU0985481810.HKD","BK4534","SG9999013999.USD","LU1883839398.USD","BK4588","LU1894683264.USD","SG9999002224.SGD","BK4139","LU0225771236.USD","SG9999003800.SGD","LU0456855351.SGD","SGXZ57979304.SGD","LU0306807586.USD","IE0002270589.USD","BK4585","LU0122379950.USD","BK4581","IE00B19Z3B42.SGD","LU1894683348.USD","LU0306806265.USD","LU0170899867.USD","LU1023059063.AUD","IE00BLSP4239.USD","LU0321505868.SGD","IE000M9KFDE8.USD","LU0289739699.SGD","PFE","LU1066051498.USD","BK4568","SG9999001176.SGD","BK4007","MTSR"],"gpt_icon":0},{"id":"2580730219","title":"Novo Nordisk Submits Amended Proposal to Acquire Metsera","url":"https://stock-news.laohu8.com/highlight/detail?id=2580730219","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580730219?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:15","pubTimestamp":1762265712,"startTime":"0","endTime":"0","summary":"Novo Nordisk Submits Amended Proposal to Acquire Metsera","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"712e45e587dc4f5fe494ffc919703b1d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MTSR","BK4532","LU0154236417.USD","LU1093756325.SGD","BK4585","BK4588","LU1093756168.USD","BK4139","NVO","BK4599","IE00BKVL7J92.USD","BK4007","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"2580730126","title":"BRIEF-Pfizer And Novo Nordisk Sweeten Offers For Metsera As Bidding War Intensifies - FT","url":"https://stock-news.laohu8.com/highlight/detail?id=2580730126","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580730126?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:14","pubTimestamp":1762265673,"startTime":"0","endTime":"0","summary":"BRIEF-Pfizer And Novo Nordisk Sweeten Offers For Metsera As Bidding War Intensifies - FTNov 4 (Reuters) - PFIZER AND NOVO NORDISK SWEETEN OFFERS FOR METSERA AS BIDDING WAR INTENSIFIES - FTSource text: https://tinyurl.com/27qo7x2l ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"712e45e587dc4f5fe494ffc919703b1d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nFWN3WG16O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","IE00BLSP4452.SGD","BK4568","LU0985481810.HKD","IE00BLSP4239.USD","IE0002270589.USD","LU1894683348.USD","BK4139","SGXZ57979304.SGD","LU1883839398.USD","LU0868494617.USD","IE00B19Z3581.USD","SG9999013999.USD","LU1057294990.SGD","LU0321505439.SGD","LU0321505868.SGD","BK4581","BK4592","SG9999001176.SGD","BK4550","SG9999002224.SGD","LU0289739699.SGD","LU0170899867.USD","BK4588","BK4585","LU1894683264.USD","SG9999011175.SGD","BK4599","LU0456855351.SGD","LU1066053197.SGD","IE00BBT3K403.USD","BK4534","LU0122379950.USD","BK4533","IE000M9KFDE8.USD","LU0306806265.USD","SG9999003800.SGD","LU0058720904.USD","MTSR","LU0225771236.USD","LU0306807586.USD","LU1066051498.USD","PFE","LU0225284248.USD","LU0234572021.USD","SG9999002232.USD","SG9999001176.USD","IE00B19Z3B42.SGD","BK4007"],"gpt_icon":0},{"id":"2580730426","title":"Novo Nordisk sweetens bid for Metsera with an offer of up to $10 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2580730426","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580730426?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:14","pubTimestamp":1762265667,"startTime":"0","endTime":"0","summary":"Novo Nordisk sweetens bid for Metsera with an offer of up to $10 billionNov 4  - Novo Nordisk NOVOb.CO is now offering up to $10 billion for Metsera MTSR.O, up from its prior offer of up to $8.5 billion, the obesity drug developer said on Tuesday.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"712e45e587dc4f5fe494ffc919703b1d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nL4N3WG1GR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","LU0306807586.USD","LU1023059063.AUD","SG9999003800.SGD","LU0234572021.USD","LU0058720904.USD","SG9999002232.USD","SG9999002224.SGD","BK4007","IE00BBT3K403.USD","LU0225284248.USD","LU0985481810.HKD","LU0122379950.USD","LU1066051498.USD","LU1066053197.SGD","BK4534","IE00BLSP4452.SGD","BK4533","SG9999001176.USD","LU0306806265.USD","BK4581","LU0289739699.SGD","SG9999013999.USD","BK4550","LU0170899867.USD","LU0868494617.USD","LU1894683348.USD","BK4568","BK4585","LU0456855351.SGD","SG9999011175.SGD","BK4592","IE00B19Z3581.USD","IE0002270589.USD","LU0321505439.SGD","BK4599","LU1057294990.SGD","SG9999001176.SGD","BK4588","LU1894683264.USD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU0225771236.USD","SGXZ57979304.SGD","LU1883839398.USD","MTSR","BK4139","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2580730981","title":"Pfizer and Novo Nordisk Sweeten Offers for Metsera as Bidding War Intensifies - FT","url":"https://stock-news.laohu8.com/highlight/detail?id=2580730981","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580730981?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:12","pubTimestamp":1762265533,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"712e45e587dc4f5fe494ffc919703b1d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nFWN3WG16O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1057294990.SGD","LU1066053197.SGD","LU0985481810.HKD","LU0122379950.USD","LU0321505439.SGD","LU1066051498.USD","BK4599","LU1883839398.USD","SGXZ57979304.SGD","LU0321505868.SGD","LU0289739699.SGD","LU0058720904.USD","SG9999001176.SGD","PFE","SG9999002224.SGD","LU1023059063.AUD","BK4534","BK4588","IE00BBT3K403.USD","LU0225771236.USD","BK4581","IE00B19Z3581.USD","SG9999001176.USD","LU1894683264.USD","IE00B19Z3B42.SGD","LU0456855351.SGD","LU0234572021.USD","SG9999002232.USD","LU0306807586.USD","LU0868494617.USD","SG9999013999.USD","BK4550","LU1894683348.USD","BK4007","LU0225284248.USD","MTSR","BK4585","BK4568","IE0002270589.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","SG9999003800.SGD","BK4533","SG9999011175.SGD","BK4139","IE000M9KFDE8.USD","LU0170899867.USD","LU0306806265.USD","BK4592"],"gpt_icon":0},{"id":"2580573066","title":"Metsera Board Deems Novo Nordisk Offer Superior but Reaffirms Support for Pfizer Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2580573066","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580573066?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:09","pubTimestamp":1762265389,"startTime":"0","endTime":"0","summary":"Metsera, Inc. disclosed that its Board of Directors has determined a revised acquisition proposal from Novo Nordisk A/S to be a \"Superior Company Proposal\" compared to its existing agreement with Pfizer. Under the terms of its current agreement with Pfizer, Metsera and Pfizer now have a two-day period to negotiate potential adjustments. The Pfizer Merger Agreement remains in effect, and no action is currently required from Metsera shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metsera Inc. published the original content used to generate this news brief via PR Newswire  on November 04, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"712e45e587dc4f5fe494ffc919703b1d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nNDL3bT9n4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","BK4568","BK4588","LU0058720904.USD","LU0122379950.USD","LU1066053197.SGD","SG9999011175.SGD","LU0321505868.SGD","BK4534","IE0002270589.USD","SGXZ57979304.SGD","BK4581","LU0321505439.SGD","BK4007","BK4550","MTSR","PFE","LU1883839398.USD","BK4585","LU0234572021.USD","LU1066051498.USD","IE00B19Z3581.USD","IE00BBT3K403.USD","SG9999001176.USD","BK4599","LU1894683348.USD","LU0225284248.USD","LU0306807586.USD","SG9999002224.SGD","BK4592","LU0306806265.USD","LU1023059063.AUD","LU0289739699.SGD","IE00BLSP4452.SGD","BK4139","LU1894683264.USD","LU0456855351.SGD","LU1057294990.SGD","SG9999013999.USD","IE00B19Z3B42.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU0170899867.USD","SG9999003800.SGD","SG9999001176.SGD","IE00BLSP4239.USD","LU0225771236.USD","SG9999002232.USD","BK4533"],"gpt_icon":0},{"id":"2580730954","title":"Metsera Inc:  Revised Pfizer Proposal Adopted Same Commercially Reasonable Efforts Standard for CVR as in Novo Nordisk Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2580730954","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580730954?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:09","pubTimestamp":1762265364,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"712e45e587dc4f5fe494ffc919703b1d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nTUA3KRTCW:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BLSP4452.SGD","BK4533","LU0456855351.SGD","BK4550","LU0225771236.USD","LU0321505439.SGD","LU0306806265.USD","IE00BBT3K403.USD","LU0225284248.USD","SGXZ57979304.SGD","BK4599","LU0170899867.USD","BK4007","SG9999011175.SGD","SG9999002232.USD","MTSR","PFE","IE00B19Z3581.USD","SG9999003800.SGD","LU0289739699.SGD","LU1883839398.USD","IE00BLSP4239.USD","BK4568","LU1066051498.USD","SG9999001176.SGD","LU0985481810.HKD","LU0234572021.USD","BK4585","BK4588","BK4581","LU1057294990.SGD","IE0002270589.USD","LU0058720904.USD","BK4592","SG9999001176.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","SG9999002224.SGD","LU0122379950.USD","LU1894683264.USD","LU1894683348.USD","BK4139","LU0306807586.USD","IE000M9KFDE8.USD","BK4534","LU0321505868.SGD","SG9999013999.USD","LU1023059063.AUD","LU0868494617.USD"],"gpt_icon":0},{"id":"2580730932","title":"Metsera Inc:  Revised Pfizer Proposal Required a Shareholder of Metsera to Sell Pfizer 14.9% of Common Stock of Metsera Upon Signing of Transaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2580730932","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580730932?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:09","pubTimestamp":1762265364,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ba68da69f867f81f24ac210d57b4bbd9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nTUA3KRTCW:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0058720904.USD","LU0321505439.SGD","LU0225284248.USD","SG9999002232.USD","LU0868494617.USD","LU1066053197.SGD","LU0234572021.USD","IE00BLSP4452.SGD","BK4533","SG9999001176.USD","SG9999011175.SGD","IE00BBT3K403.USD","IE00B19Z3581.USD","BK4550","BK4599","LU1057294990.SGD","BK4592","LU0985481810.HKD","BK4534","SG9999013999.USD","LU1883839398.USD","BK4588","LU1894683264.USD","SG9999002224.SGD","BK4139","LU0225771236.USD","SG9999003800.SGD","LU0456855351.SGD","SGXZ57979304.SGD","LU0306807586.USD","IE0002270589.USD","BK4585","LU0122379950.USD","BK4581","IE00B19Z3B42.SGD","LU1894683348.USD","LU0306806265.USD","LU0170899867.USD","LU1023059063.AUD","IE00BLSP4239.USD","LU0321505868.SGD","IE000M9KFDE8.USD","LU0289739699.SGD","PFE","LU1066051498.USD","BK4568","SG9999001176.SGD","BK4007","MTSR"],"gpt_icon":0},{"id":"2580730373","title":"Metsera Inc - Novo Nordisk Proposal Values Metsera at $86.20 per Share, $10 Bln Total","url":"https://stock-news.laohu8.com/highlight/detail?id=2580730373","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580730373?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:09","pubTimestamp":1762265364,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"712e45e587dc4f5fe494ffc919703b1d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nTUA3KRTCW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MTSR","BK4139"],"gpt_icon":0},{"id":"2580303757","title":"Metsera Inc - Pfizer Merger Agreement Remains in Effect","url":"https://stock-news.laohu8.com/highlight/detail?id=2580303757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580303757?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:09","pubTimestamp":1762265364,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nTUA3KRTCW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0321505868.SGD","BK4139","BK4534","LU0289739699.SGD","LU1023059063.AUD","SG9999011175.SGD","IE00BLSP4452.SGD","IE0002270589.USD","LU0985481810.HKD","LU0306806265.USD","LU0456855351.SGD","MTSR","LU0058720904.USD","SG9999003800.SGD","BK4599","SGXZ57979304.SGD","SG9999001176.USD","IE00B19Z3B42.SGD","BK4007","LU1883839398.USD","IE00BBT3K403.USD","LU1057294990.SGD","LU0122379950.USD","LU1066053197.SGD","LU1066051498.USD","IE000M9KFDE8.USD","PFE","IE00BLSP4239.USD","LU0225771236.USD","LU0234572021.USD","LU1894683264.USD","LU0321505439.SGD","BK4581","BK4588","SG9999013999.USD","BK4568","LU0868494617.USD","LU1894683348.USD","BK4550","SG9999002232.USD","IE00B19Z3581.USD","BK4592","LU0225284248.USD","LU0170899867.USD","LU0306807586.USD","SG9999002224.SGD","BK4585","BK4533","SG9999001176.SGD"],"gpt_icon":0},{"id":"2580154730","title":"Metsera:  Revised Pfizer Proposal Required Co to Issue a Release Stating \"Novo Nordisk Proposal Presented Unacceptably High Risks and Was Unviable\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2580154730","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580154730?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:09","pubTimestamp":1762265364,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"712e45e587dc4f5fe494ffc919703b1d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nTUA3KRTCW:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4592","LU1023059063.AUD","BK4599","IE00BBT3K403.USD","LU0170899867.USD","SG9999002224.SGD","LU0306807586.USD","LU0321505868.SGD","LU0234572021.USD","LU0306806265.USD","BK4581","BK4139","LU1066051498.USD","BK4007","LU0985481810.HKD","LU0289739699.SGD","LU0868494617.USD","IE00BLSP4452.SGD","LU1883839398.USD","SG9999001176.SGD","LU1894683348.USD","BK4534","SG9999011175.SGD","IE00B19Z3B42.SGD","BK4588","BK4550","SGXZ57979304.SGD","SG9999001176.USD","LU0321505439.SGD","MTSR","LU0122379950.USD","IE00BLSP4239.USD","SG9999003800.SGD","LU0225284248.USD","LU1066053197.SGD","BK4533","SG9999013999.USD","IE00B19Z3581.USD","LU0225771236.USD","PFE","IE000M9KFDE8.USD","BK4585","LU1894683264.USD","LU1057294990.SGD","SG9999002232.USD","IE0002270589.USD","LU0456855351.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"1105159682","title":"Pfizer (PFE.US) Q3 Earnings Beat Expectations and Raises Full-Year Profit Guidance, Bids for Weight-Loss Drug Firm Metsera","url":"https://stock-news.laohu8.com/highlight/detail?id=1105159682","media":"Stock News","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105159682?lang=en_us&edition=fundamental","pubTime":"2025-11-04 21:20","pubTimestamp":1762262432,"startTime":"0","endTime":"0","summary":"Pfizer (PFE.US) reported better-than-expected Q3 2025 earnings and raised its full-year profit forecast, citing cost-cutting measures that helped offset slowing sales growth. The financial boost also...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"44a4d18192a8bab548913ffbb664148d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU1066053197.SGD","LU0985481810.HKD","LU0122379950.USD","LU0321505439.SGD","LU1066051498.USD","BK4599","LU1883839398.USD","SGXZ57979304.SGD","LU0321505868.SGD","LU0289739699.SGD","LU0058720904.USD","SG9999001176.SGD","PFE","SG9999002224.SGD","LU1023059063.AUD","BK4534","BK4588","IE00BBT3K403.USD","LU0225771236.USD","BK4581","IE00B19Z3581.USD","SG9999001176.USD","LU1894683264.USD","IE00B19Z3B42.SGD","LU0456855351.SGD","LU0234572021.USD","SG9999002232.USD","LU0306807586.USD","LU0868494617.USD","SG9999013999.USD","BK4550","LU1894683348.USD","BK4007","LU0225284248.USD","MTSR","BK4585","BK4568","IE0002270589.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","SG9999003800.SGD","BK4533","SG9999011175.SGD","BK4139","IE000M9KFDE8.USD","LU0170899867.USD","LU0306806265.USD","BK4592"],"gpt_icon":1},{"id":"2580731902","title":"RPT-BREAKINGVIEWS-Pfizer’s obesity takeover requires a booster shot","url":"https://stock-news.laohu8.com/highlight/detail?id=2580731902","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580731902?lang=en_us&edition=fundamental","pubTime":"2025-11-04 21:00","pubTimestamp":1762261200,"startTime":"0","endTime":"0","summary":"RPT-BREAKINGVIEWS-Pfizer’s obesity takeover requires a booster shotThe author is a Reuters Breakingviews columnist. The opinions expressed are her own.By Aimee  Donnellan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nL6N3WF0SN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00B19Z3B42.SGD","SGXZ57979304.SGD","SG9999002232.USD","LU0122379950.USD","IE00BLSP4452.SGD","SG9999001176.USD","LU0058720904.USD","IE00B19Z3581.USD","BK4139","BK4550","BK4588","LU1894683264.USD","LU0306806265.USD","LU0321505868.SGD","LU0225771236.USD","SG9999001176.SGD","SG9999002224.SGD","IE00BLSP4239.USD","LU1066051498.USD","LU0868494617.USD","LU1894683348.USD","LU1066053197.SGD","MTSR","LU1057294990.SGD","LU0289739699.SGD","LU0306807586.USD","LU0985481810.HKD","LU1023059063.AUD","BK4592","BK4599","BK4568","LU0225284248.USD","LU0234572021.USD","LU1883839398.USD","IE000M9KFDE8.USD","LU0170899867.USD","LU0456855351.SGD","SG9999013999.USD","IE0002270589.USD","SG9999003800.SGD","SG9999011175.SGD","BK4007","BK4581","PFE","LU0321505439.SGD","BK4534","BK4533","IE00BBT3K403.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":199,"code":"91000000","status":"200"}]}}